v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities      
Loss for the period $ (20,599) $ (20,588)  
Items not affecting cash:      
Amortization 39 58  
Accrued interest on credit facilities   558  
Lease expense 477 477 $ 1,907
Share-based compensation and expenses settled with equity 23,975 10,378  
Equity-accounted investment loss 2,998 35  
Gain on dilution of investment (4,602)    
Change in fair value of warrants liability (10,662) 441  
Unrealized foreign exchange movement (726) 2,345  
Interest paid on short-term debt   (103)  
Changes in working capital:      
Receivables and prepayments (48) (3,161)  
Accounts payable and accrued liabilities 8,533 213  
Net cash used in operating activities (615) (9,347)  
Investing activities      
Acquisition of equipment and software (35) (70)  
Net cash used in investing activities (35) (70)  
Financing activities      
Proceeds from exercise of stock options 2,719    
Proceeds from registered direct offering   5,000  
Expenses paid for registered direct offering   (472)  
Proceeds from Shares issued from ATM   5,562  
Repayment of Debt   (1,797)  
Net cash provided by financing activities 2,719 8,293  
Increase/(Decrease) in cash 2,069 (1,124)  
Impact of exchange rate changes on cash (20) (10)  
Cash - beginning of period 117,633 3,480 3,480
Cash - end of period $ 119,682 $ 2,346 $ 117,633